What is the recommended treatment for herpes zoster (shingles) pain?

Treatment of Shingles Pain

For acute shingles pain, start oral antiviral therapy (valacyclovir or famciclovir preferred over acyclovir) within 72 hours of rash onset, combined with appropriate analgesics; for postherpetic neuralgia, use gabapentin as first-line treatment, with pregabalin, tricyclic antidepressants, or topical capsaicin as alternatives.

Acute Shingles Pain Management

Antiviral Therapy

The cornerstone of acute herpes zoster treatment is early antiviral therapy, which reduces pain severity, shortens the eruptive phase, and decreases the risk of postherpetic neuralgia 1, 2, 3.

• Timing is critical: Initiate treatment within 72 hours of rash onset 1, 2
• Preferred agents: Valacyclovir or famciclovir over acyclovir due to better dosing convenience 3
• Duration: Continue for 7-10 days minimum 1

For immunocompromised patients: Use higher doses of oral valacyclovir or famciclovir for uncomplicated cases. Switch to intravenous acyclovir for complicated presentations (multi-dermatomal, ophthalmic, visceral, or disseminated disease) 1.

Acute Pain Control

Combine antivirals with analgesics appropriate to pain severity. The evidence supports multimodal pain management during the acute phase, though specific recommendations vary by pain intensity and patient factors 4, 2.

Postherpetic Neuralgia Treatment

Postherpetic neuralgia (PHN), defined as pain persisting beyond 90 days after rash onset, occurs in 10-18% of shingles cases and represents the most debilitating complication 5, 2.

First-Line Pharmacologic Options

Gabapentin is the primary recommended oral agent for neuropathic pain 6:

• Titrate to 2400 mg daily in divided doses
• Provides additional benefit for sleep disturbances
• Somnolence occurs in approximately 80% of patients

Pregabalin is specifically recommended for postherpetic neuralgia when gabapentin response is inadequate 6:

• Number needed to treat (NNT) of 4.93 for PHN 6
• Effective alternative with similar mechanism to gabapentin

Tricyclic antidepressants (TCAs):

• NNT of 2.64 for PHN 6
• Consider when gabapentin fails or as alternative first-line option
• Particularly effective but monitor for anticholinergic side effects in older adults

Serotonin-norepinephrine reuptake inhibitors (SNRIs):

• Reasonable alternative when gabapentin inadequate 6
• Based on effectiveness in general neuropathic pain populations

Topical Therapies

Capsaicin 8% patch has strong evidence for chronic neuropathic pain 6:

• Single 30-minute application provides relief for at least 12 weeks
• Apply 4% lidocaine for 60 minutes before capsaicin to reduce application discomfort
• Common side effects: erythema and pain at application site
• NNT of 3.26 for PHN 6

Lidocaine patches:

• NNT of 2.0 for PHN 6
• Useful adjunctive topical treatment
• Minimal systemic absorption

Treatment Algorithm for PHN

1. Start with gabapentin (titrate to 2400 mg/day) as first-line oral therapy
2. If inadequate response, consider:
   • Pregabalin (especially for confirmed PHN)
   • Tricyclic antidepressants
   • SNRIs
3. Add topical therapy at any stage:
   • Capsaicin 8% patch (every 12 weeks)
   • Lidocaine patches (daily as needed)
4. Avoid opioids as first-line for chronic neuropathic pain 6

Important Clinical Considerations

Immunocompromised Patients

• Higher risk for severe disease and complications 7, 1
• May require intravenous acyclovir for complicated presentations
• Consider withholding immunosuppressive therapy in severe cases until skin vesicles resolve 1

Common Pitfalls

• Delayed antiviral treatment: The 72-hour window is crucial for optimal benefit
• Underdosing antivirals: Use appropriate higher doses for VZV (not HSV dosing)
• Premature opioid use: Reserve opioids for refractory cases after trying evidence-based neuropathic pain medications
• Inadequate gabapentin titration: Many patients need the full 2400 mg/day dose

Prevention Context

While not directly addressing acute pain treatment, vaccination with recombinant zoster vaccine (RZV) is the most effective strategy to prevent both shingles and PHN, recommended for adults ≥50 years and immunocompromised adults ≥18 years 8, 5, 9.